These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 10502438

  • 1. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
    Meiser B, Butow P, Barratt A, Friedlander M, Gattas M, Kirk J, Suthers G, Walpole I, Tucker K.
    Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
    [Abstract] [Full Text] [Related]

  • 2. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B.
    Cancer; 2006 Dec 15; 107(12):2745-51. PubMed ID: 17109443
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer.
    Antill Y, Reynolds J, Young MA, Kirk J, Tucker K, Bogtstra T, Wong S, Dudding T, Di Iulio J, Phillips KA.
    Eur J Cancer; 2006 Mar 15; 42(5):621-8. PubMed ID: 16434187
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prophylactic oophorectomy in women at increased cancer risk.
    Domchek SM, Rebbeck TR.
    Curr Opin Obstet Gynecol; 2007 Feb 15; 19(1):27-30. PubMed ID: 17218848
    [Abstract] [Full Text] [Related]

  • 9. An exploratory qualitative study of women's perceptions of risk management options for familial ovarian cancer: implications for informed decision making.
    Brain K, Gravell C, France E, Fiander A, Gray J.
    Gynecol Oncol; 2004 Mar 15; 92(3):905-13. PubMed ID: 14984959
    [Abstract] [Full Text] [Related]

  • 10. A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.
    Michelsen TM, Dørum A, Dahl AA.
    Gynecol Oncol; 2009 Apr 15; 113(1):128-33. PubMed ID: 19178933
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prophylactic oophorectomy and ovarian cancer surveillance. Patient perceptions and satisfaction.
    Swisher EM, Babb S, Whelan A, Mutch DG, Rader JS.
    J Reprod Med; 2001 Feb 15; 46(2):87-94. PubMed ID: 11255821
    [Abstract] [Full Text] [Related]

  • 13. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
    Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH.
    Obstet Gynecol; 2006 Sep 15; 108(3 Pt 1):515-20. PubMed ID: 16946209
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.
    Lerman C, Hughes C, Croyle RT, Main D, Durham C, Snyder C, Bonney A, Lynch JF, Narod SA, Lynch HT.
    Prev Med; 2000 Jul 15; 31(1):75-80. PubMed ID: 10896846
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Ouweland AW, van Geel B, Klijn JG.
    J Clin Oncol; 2003 May 01; 21(9):1675-81. PubMed ID: 12721241
    [Abstract] [Full Text] [Related]

  • 17. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.
    Rebbeck TR.
    J Clin Oncol; 2000 Nov 01; 18(21 Suppl):100S-3S. PubMed ID: 11060335
    [Abstract] [Full Text] [Related]

  • 18. Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy.
    Dowdy SC, Stefanek M, Hartmann LC.
    Am J Obstet Gynecol; 2004 Oct 01; 191(4):1113-23. PubMed ID: 15507929
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
    Lamb JD, Garcia RL, Goff BA, Paley PJ, Swisher EM.
    Am J Obstet Gynecol; 2006 Jun 01; 194(6):1702-9. PubMed ID: 16731090
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.